Meningococcal Disease Vaccine
14augAll Day12Meningococcal Disease VaccineRecruitment Closed
Clinical Study Details
Meningococcal disease is rare, but if contracted, it can progress suddenly. The disease can cause devastating lifelong impairments and can be fatal. Currently, there are two available vaccines for Meningococcal disease.
Clinical Study Details
Meningococcal disease is rare, but if contracted, it can progress suddenly. The disease can cause devastating lifelong impairments and can be fatal.
Currently, there are two available vaccines for Meningococcal disease. One vaccine protects against the A, C, W and Y strains and the other vaccine protects against the B strains of the disease. AusTrials is conducting a research study to test a new investigational vaccine that combines the 5 main strains of the disease into the one vaccine (ABCWY).
The study will involve 6 clinic visits over a 12-month period. Participants will be asked to give blood to assess how the body reacts to the vaccine, answer questions about participant health and complete an electronic diary to collect health information after vaccination. In total, participants will receive 4 injections (vaccines).
You may be eligible to take part if:
- You are healthy and between 10 and 25 years old
- You have never had a vaccine against any of the 5 Meningococcal strains (A, B, C, W or Y). However, you can still join the study if you received a Meningococcal C strain vaccine at or before 24 months of age.
The study is being conducted at the following locations:
- Taringa, QLD
- Wellers Hill, QLD
Qualified participants will receive:
- Vaccinations and visits at no cost
- Compensation for time and travel involved in the study
Please contact AusTrials on 07 3278 5255 for further information, or fill out the form below and we will get back to you.
Use the links at the bottom of the page to share this study on social media or by email with friends or family who may be interested.
Potential participants under 18 years must be accompanied by a parent or a legal guardian at all study visits, who must consent to study participation.
Time
august 14 (Friday) - 12 (Friday)
Location
Multiple Sites